# Electronic Prescription Management System (e-Prescribing)

## Feature Overview

The Electronic Prescription Management System enables licensed healthcare providers to create, validate, transmit, and track medication prescriptions digitally from point of care to dispensing pharmacy. The system replaces paper prescriptions and fax-based workflows with a structured, auditable digital flow that incorporates real-time clinical decision support (drug-drug interactions, allergy checks, dosage validation), formulary verification, and integration with the national e-prescription infrastructure and the cross-border eHDSI (eHealth Digital Service Infrastructure) network. The platform supports both human and veterinary prescriptions, handles controlled substances with enhanced authentication, and provides full audit traceability required for clinical, regulatory, and forensic review.

## Business Value

Manual prescription processes generate measurable patient harm and operational waste. Internal audit of paper-prescription incidents in the participating hospital network shows 4.2% of prescriptions contain at least one error (illegibility, wrong dose, missed allergy, duplicate therapy), with 0.3% reaching the patient as administered medication errors. The European Medicines Agency estimates avoidable medication errors cost EU healthcare systems €4.5 billion annually.

The system targets a 70% reduction in prescription-related medication errors through structured entry and automated safety checks, elimination of legibility-driven dispensing delays (currently averaging 12 minutes per ambiguous paper script), and reduction of pharmacist callback rate from 8% to under 2%. Secondary benefits include improved adherence tracking (dispensed-vs-prescribed reconciliation), faster controlled substance reconciliation, and the ability to participate in cross-border prescription dispensing for EU patients traveling within the bloc.

## User Personas

| Persona | Description | Primary Needs | Key Constraints |
|---|---|---|---|
| Prescribing Physician | GP or specialist writing prescriptions during consultations | Fast entry, integrated history, decision support that doesn't interrupt workflow | Limited consultation time (avg. 12 min), alert fatigue risk |
| Hospital Resident | Junior doctor in inpatient setting | Supervisor co-sign workflow, formulary guidance | Less prescribing experience, higher error risk |
| Community Pharmacist | Dispensing pharmacist at retail pharmacy | Clear prescription details, ability to flag concerns, substitution rules | Volume pressure, dispensing window legal limits |
| Hospital Pharmacist | Clinical pharmacist reviewing inpatient orders | Therapeutic appropriateness review, IV compatibility, dose verification | Must review before administration, time-critical for some orders |
| Patient | End recipient of prescription | Understanding of what was prescribed, pickup at any participating pharmacy | Variable health literacy, may not speak local language |
| Practice Administrator | Manages prescriber accounts and credentials | Onboarding, license verification, audit reporting | Regulatory burden, GDPR obligations |

## Process Overview

### Prescription Initiation

A prescription begins within a clinical encounter — outpatient consultation, hospital ward round, emergency department visit, or telemedicine session. The prescriber, authenticated to the EHR with at least two-factor authentication (smartcard or eIDAS-equivalent for controlled substances), opens the prescribing interface from within the patient's clinical record. The system loads the patient's current medication list, known allergies and intolerances, relevant lab results (renal and hepatic function for dose adjustment), and active diagnoses (ICD-10) which may inform appropriateness.

The prescriber selects a medication. Search supports brand name, INN (international nonproprietary name), ATC code, and indication-based search ("antibiotic for UTI"). The system displays the medication with strength options, available formulations, formulary status (preferred, non-preferred, requires prior authorization, not covered), and average patient cost-share.

For each prescription, the prescriber specifies dose, route, frequency, duration, dispense quantity, refill count (zero to ten, zero only for controlled substances above schedule II equivalent), and patient instructions (free text plus structured Sig builder). The system supports common dosing templates (e.g., "amoxicillin 500mg TID x 7 days") that pre-fill the structured fields.

### Real-Time Clinical Decision Support

Before the prescription can be signed, the system executes a synchronous safety check pipeline. All checks must complete within 800 milliseconds combined to avoid disrupting clinical workflow.

The drug-drug interaction check compares the new prescription against the patient's active medication list and the proposed prescription set within this encounter. Interactions are graded as contraindicated (transmission blocked unless overridden), severe, moderate, or minor. Severe and above must be acknowledged with a documented clinical rationale. The system surfaces only the most clinically significant interaction per medication pair to reduce alert fatigue, with a "show all" expansion available.

The allergy and intolerance check compares the prescribed medication's active ingredients and known cross-reactive substance classes (e.g., penicillin → cephalosporin cross-reactivity) against the patient's documented allergies. Severity grading (anaphylaxis, hives, GI intolerance) governs whether the alert blocks transmission.

Dosage validation evaluates the prescribed dose against age, weight, renal function (eGFR), and hepatic function. Pediatric and geriatric dose checks use weight-based and age-band reference ranges respectively. Out-of-range doses require explicit acknowledgment.

Duplicate therapy detection flags prescriptions for medications in the same therapeutic class already active on the patient's medication list (e.g., two ACE inhibitors).

Pregnancy and lactation checks fire when the patient record indicates pregnancy, possible pregnancy (women of childbearing age without contraception documented), or active breastfeeding. Pregnancy category risk (FDA letter system or EU SmPC equivalent) is displayed.

### Prescription Signing and Transmission

Once the prescriber addresses all blocking alerts, they sign the prescription. Standard prescriptions are signed with the prescriber's electronic signature stored in the system. Controlled substances above the national equivalent of Schedule III require step-up authentication: hardware token, eIDAS qualified electronic signature, or biometric confirmation depending on jurisdiction.

Upon signing, the prescription is transmitted to the national e-prescription platform (e.g., NHS Spine in UK, Mein ePA / E-Rezept in Germany, NRES in Bulgaria) via the corresponding integration adapter. The patient receives an electronic prescription token (QR code, SMS, or push notification depending on patient preference and capability) which they present at any participating pharmacy for dispensing. For cross-border travelers, the prescription is also registered with the eHDSI NCPeH (National Contact Point for eHealth) gateway.

### Dispensing Reconciliation

When a pharmacy dispenses against the prescription, the national platform notifies the e-prescribing system. The prescription status updates from "Issued" to "Partially Dispensed" or "Fully Dispensed". The dispensing event records the dispensing pharmacy, pharmacist identifier, dispensed product (which may differ from prescribed if substitution is allowed under formulary rules), dispensed quantity, and dispensing timestamp.

If the dispensed product differs from the prescribed product (generic substitution, strength adjustment within allowed bounds, or therapeutic interchange under protocol), the substitution reason is captured and the substitution is visible to the prescriber on next encounter.

### Renewal, Modification, and Cancellation

Patients can request renewals through the patient portal, by contacting the practice, or via pharmacy-initiated renewal request. Renewal requests appear in the prescriber's task queue with prior prescription details pre-populated. The prescriber may renew as-is, modify, or decline with reason.

Modifications to active, undispensed prescriptions are supported with two patterns: cancel-and-reissue (issues a new prescription, cancels the original) and amendment (for clerical corrections to instructions only, not clinical content). The system blocks amendment of clinical content (drug, dose, route, frequency) — these require cancellation and reissue.

Cancellation propagates to the national platform and, if the prescription has not been dispensed, to any pharmacy that has reserved it. If the prescription has been partially dispensed, cancellation applies only to the remaining quantity.

### Error Handling and Edge Cases

| Scenario | System Behavior | User Experience |
|---|---|---|
| National platform unavailable at signing | Queue for retry, mark as "Pending Transmission" | Prescriber notified; patient receives prescription only after successful transmission. Manual paper fallback workflow available with audit trail |
| Patient has no record in national platform (e.g., foreign visitor) | Route to cross-border eHDSI flow if applicable, else paper script with manual transmission | Prescriber prompted to confirm patient identification method used |
| Allergy alert override without rationale | Block signing until rationale entered (minimum 20 characters) | Inline validation, cannot dismiss |
| Controlled substance prescribed by prescriber without DEA-equivalent authorization | Block transmission, log attempt for audit | Clear explanation of missing authorization, no override available |
| Duplicate prescription within 24 hours (same drug, same patient, same prescriber) | Warn but allow with confirmation | Inline duplicate warning with link to existing prescription |
| Dispensing pharmacy reports prescription appears tampered or fraudulent | Flag prescription, notify prescriber, freeze further dispensing pending review | Prescriber receives high-priority notification; investigation workflow initiated |
| Renal function lab >90 days old | Soft warning, prescriber may proceed but must acknowledge stale data | Warning includes lab date and link to order new labs |
| Prescription created during EHR offline mode | Stored locally, signed and queued; transmitted when connectivity restored | Prescriber sees "Pending Transmission" status; patient receives prescription only after transmission succeeds |

## Functional Requirements

### Patient Medication Reconciliation

The system maintains a unified active medication list per patient consolidated from prescriptions issued by all prescribers using the platform, prescriptions reported by external sources (national platform), and patient-reported medications (OTC, supplements, externally prescribed). Each entry tracks source, confidence (verified vs. reported), and last reconciliation date. Reconciliation is required at defined clinical transitions: admission, discharge, transfer of care, and annual review for chronic patients.

### Formulary and Cost Transparency

Formulary data is integrated from each health insurance plan covering the patient. At prescription time, the system displays formulary tier (preferred generic, preferred brand, non-preferred, not covered, requires prior authorization), patient cost-share estimate, and alternatives within the same therapeutic class with their formulary status. Prior authorization requirements surface as an inline workflow: the prescriber can complete the PA request within the prescribing interface, which is transmitted to the payer for decision.

### Controlled Substance Workflow

Controlled substance prescriptions require enhanced controls aligned with national narcotics legislation. The prescriber must possess valid narcotics prescribing authorization on file (verified against the national register at the point of prescribing — not just at account creation). Prescription quantities are limited per substance class: in most EU jurisdictions, opioids are limited to 30-day supply, benzodiazepines to 30-90 days depending on class. The system enforces these limits and provides justification fields for exceptional cases. All controlled substance prescriptions are subject to monthly automated review with anomaly detection (unusual quantity, frequency, multi-prescriber patterns suggesting doctor shopping).

### Patient Portal Integration

Patients access their prescriptions through the patient portal: view active prescriptions, pickup status, refills remaining, and dispensing history. Patients can request renewals, indicate pickup pharmacy preference, and view plain-language medication information sheets in their preferred language (auto-translated from official SmPC where available). For dependents (children, legal wards), parents/guardians with documented relationship access these views on behalf.

### Audit Trail

Every action on a prescription generates an immutable audit event: creation, modification, signing, transmission, override of clinical alert (with rationale), cancellation, and dispensing event received. Audit records include prescriber identity, timestamp, IP address and device fingerprint, the action taken, and before/after state where applicable. Audit data is retained for the longer of 10 years or jurisdictional medical record retention requirement (often 30 years for pediatric records). Audit search supports queries by prescriber, patient, medication, date range, and override type for compliance review.

## Acceptance Criteria

1. Prescriber can complete a single-medication prescription including search, dose entry, decision support review, and signing in under 45 seconds for a routine prescription with no alerts triggered.
2. All synchronous clinical decision support checks (drug-drug, allergy, dose, duplicate, pregnancy) complete within 800ms total per prescription.
3. Severe and contraindicated alerts cannot be bypassed without entering a clinical rationale of at least 20 characters; rationale is stored in the audit trail.
4. Controlled substance prescriptions cannot be transmitted unless prescriber's narcotics authorization is verified valid against the national register within the past 24 hours.
5. Prescription transmission to the national e-prescription platform succeeds within 5 seconds of signing under normal conditions; failure modes trigger retry with exponential backoff and prescriber notification on persistent failure.
6. Dispensing events from the national platform are reflected in prescription status within 60 seconds of receipt.
7. Cross-border prescriptions valid under eHDSI generate the required NCPeH-compatible structured format; cross-border dispensing events are reconciled to the originating prescription.
8. All prescription actions generate audit events that are immutable, hash-chained for tamper evidence, and queryable within 2 seconds for 12 months of patient history.
9. Renal-adjusted dose recommendations display when patient eGFR is below 60 mL/min/1.73m² and the prescribed medication has documented renal dose adjustment guidance.
10. Patient portal displays prescription status, dispensing history, and refill count in real time, with translation to at least the official languages of the deployment country plus English.
11. System availability for prescription signing and transmission is 99.9% measured monthly, excluding planned maintenance windows announced 7 days in advance.
12. GDPR Article 9 (special category health data) requirements are met: encryption at rest with key rotation, access logged, lawful basis recorded, data subject access request fulfillment within 30 days.

## Dependencies

- National e-prescription platform integration (per deployment country)
- eHDSI / NCPeH gateway for cross-border prescriptions
- National narcotics register API for prescriber authorization verification
- Drug knowledge base (e.g., First Databank, Multum, or national equivalent) for clinical decision support
- Patient EHR system providing demographics, allergies, problem list, lab results
- National health identifier registry for patient identification
- eIDAS-compliant identity provider for prescriber authentication
- Insurance/payer integration for formulary and prior authorization
- Patient portal infrastructure (for patient-facing views)
- Audit log storage with immutable write semantics

## Out of Scope

- Medication administration record (MAR) for inpatient nurse documentation — separate inpatient module
- Pharmacy inventory management — handled by pharmacy systems
- Compounding prescriptions (custom pharmacy-prepared medications) — phase 2
- Veterinary prescriptions for non-companion animals (livestock prescribing has separate regulatory regime) — phase 2
- Direct integration with patient wearables for medication adherence — phase 3
- Clinical trial investigational medicinal product prescribing — separate IMP workflow
- Telehealth prescribing across international borders outside eHDSI — regulatory complexity defers this indefinitely

## Technical Considerations

Clinical decision support latency is the single hardest performance constraint. The 800ms budget must cover drug knowledge base lookup, patient medication list retrieval, lab data retrieval, and rule evaluation. Implementation should pre-cache the patient's active medication list and recent labs on encounter open, evaluate drug-drug interactions against an in-memory drug interaction matrix (hot data set), and parallelize independent checks. Alert content rendering should use server-side composition to avoid round trips for translations and references.

Audit log integrity is regulatory-critical. Use append-only storage with cryptographic hash chaining (each record includes hash of previous record), separate from operational database, with periodic external timestamp anchoring (e.g., RFC 3161 trusted timestamp). Audit data residency must match patient data residency (within EU for EU patients).

National platform integrations are the highest fragility surface. Each country has different protocols (NHS uses HL7v3 over MESH; Germany uses Telematikinfrastruktur with VAU encryption; Bulgaria uses NHIF endpoints with SOAP). Abstract behind a normalized internal interface but maintain per-country adapter modules with isolated failure domains. Circuit breakers prevent one country's outage from cascading. All transmissions are idempotent with provider-issued correlation IDs.

GDPR Article 9 health data requires lawful basis tracking per processing purpose. Build the consent and lawful-basis layer once and apply consistently — retrofitting this is painful. Pseudonymization for analytics use cases must be irreversible from the analytics environment. Right to erasure for prescription data is constrained by medical record retention law and must be handled with care: erasure typically means transfer to legal archive rather than deletion.

Drug knowledge base content licensing is non-trivial and per-country. Plan for the licensing cost in operational budget and the integration cost in engineering. Updates from the vendor must be reviewed clinically before activation — never auto-deploy drug knowledge updates to production without a clinical pharmacist signing off.

The system handles safety-critical data flows. Test coverage requirements should exceed typical SaaS standards: every clinical decision support rule needs dedicated test cases covering positive, negative, and edge cases; every alert override path needs audit verification; failover modes need rehearsed runbooks. Post-market surveillance reporting (MDR Article 83 for software qualifying as a medical device) requires structured incident capture and may apply depending on national interpretation of decision support classification.
